ASP-3026

Categories
Therapeutic
Curator
Karen Rothfels
Designer
Cristoffer Sevilla
Description
ASP-3026 is a second generation ALK inhibitor designed to target ALK rearrangements which are the oncogenic drivers of some non-small cell lung cancers (NSCLCs) and T-cell lymphomas known as ALK- expressing anaplastic large-cell lymphoma (ALK+ALCL) .
Icon preview
Icon ASP-3026
SVG
PNG
EMF
Locations in the PathwayBrowser
Expand all
Entries for ASP-3026
ASP-3026 [cytosol]
External References
IUPHAR
Cite Us!